Portal vein stent for narrowed portal blood vessels
Part of Cancer, Digestive system clinical trials.
This trial looks at whether placing a small metal stent in the portal vein and nearby veins can improve problems caused by major narrowing (or clotting) of these vessels in people with gastrointestinal cancers. If you have significant vessel narrowing, the study may offer a targeted way to relieve pressure and symptoms that are not caused by the tumor directly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have gastrointestinal cancer and need standard staging/treatment first
- You have major narrowing (>75%) in the portal vein or nearby mesenteric veins (including the SMV)
- This narrowing may be with or without symptoms, for the “any narrowing” pathway
- If you do have symptoms like bleeding from stomach/esophagus veins, stubborn fluid buildup, abdominal pain, swelling in the intestines, or diarrhea, they must not be explained by tumor spread into the vessel or peritoneum
- You may qualify if you have a main portal vein clot/narrowing but did not receive a stent yet (a separate group for this)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to stop bleeding from enlarged veins in the esophagus or stomach caused by a blocked portal vein. It uses an approach through a different vein in the belly, for people who can't have or didn't benefit from the usual shunt procedure.
This trial tests a new covered stent placed directly into the liver to relieve high blood pressure in the portal vein (the main vein to the liver) and reduce complications like bleeding and fluid build-up. It may offer an option for people with cirrhosis who need a TIPS procedure.
This study tests a minimally invasive procedure to restore blood flow in children with a blocked portal vein (the major vein carrying blood from the intestines to the liver). It aims to reduce complications like bleeding from enlarged veins in the stomach or esophagus, an enlarged spleen, or fluid buildup in the belly.
This trial tests a combination of treatments for liver cancer that has spread to the main portal vein. It uses a special stent, radiation seeds, and targeted therapies to shrink the tumor and improve blood flow. This may help patients who haven't had certain prior treatments.
This study tests a combined procedure to stop bleeding from enlarged veins in the food pipe (varices) in people with a rare condition called cavernous transformation of the portal vein. The treatment involves blocking the bleeding veins and reducing blood flow to the spleen to prevent future bleeding.
This study collects medical data and images from people with portal hypertension who have enlarged veins in the esophagus or stomach. It aims to build a database for future research.
Hear when a new Malignant Digestive System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.